Skip to content
Open access

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types

Aug 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 49 references
Medicine

TL;DR

CD8 T-cell populations showed the strongest methodological concordance, establishing their priority as a robust candidate biomarker for immune activation to be used in further clinical research.

Abstract

Background Immune cell populations within the tumor microenvironment (TME) critically determine cancer prognosis and therapeutic response. Although multiplexed immunohistochemistry (mIHC) provides spatial immune profiling and bulk RNA sequencing methods offer comprehensive cellular characterization, comparative studies between these complementary methodologies remain limited across diverse tumor types. Methods Patient samples from various tumor types, obtained from either primary or metastatic sites, were collected. For each patient, two samples were analyzed, one for mIHC and one for RNA-seq (xCell2). Both methodologies were intended to quantify immune cell populations including CD4 and CD8 T cells, regulatory T cells (Tregs), B cells and macrophages within the TME. Samples were stratified by origin according to biopsy procedure and tissue block characteristics. The primary objective was to assess concordance between methodologies for immune cell density estimation, while exploratory analysis evaluated liver-specific TME differences and immunotherapy (IO) exposure in head and neck squamous cell carcinoma (HNSCC) patients. Method correlations were analyzed using Spearman’s rank correlation coefficient. Results Among 298 patient specimens spanning 20 tumor types, overall correlation between mIHC and xCell2 deconvolution was modest (ρ 0.35 – 0.50), due to sample heterogeneity, with CD8 T cells demonstrating the strongest correlation (ρ = 0.50). Tumor-specific analysis revealed enhanced correlations in HNSCC (ρ = 0.80) and renal clear cell carcinoma (ρ = 0.85) for CD8 T cells, while primary tumor samples showed improved CD8 T-cell correlation compared to metastatic sites (ρ = 0.60). Macrophage density was significantly elevated in primary hepatocellular carcinoma versus liver metastases (p = 0.0336). Within the HNSCC subgroup, IO-exposed samples exhibited significantly reduced CD4 T-cell (p = 0.039) and B-cell (p = 0.022) infiltration compared to treatment naïve specimens. Conclusions Our work highlights the value of integrating spatial (mIHC) and transcriptomic (xCell2) approaches to optimize immune profiling accuracy in complex tumor tissues. CD8 T-cell populations showed the strongest methodological concordance, establishing their priority as a robust candidate biomarker for immune activation to be used in further clinical research.

Read PDF

Similar papers

Open access Aug 2026

Bioinformatics analysis and experimental validation of EOMES expression and correlation with exhausted CD8+ T cell in colorectal cancer

Colorectal cancer (CRC) ranks among the most prevalent malignancies globally, yet exhibits limited responsiveness to immunotherapy. This therapeutic challenge stems primarily from incomplete understanding of immune microenvironment regulation in CRC. Although Eomesodermin (EOMES) has been implicated in tumor immune che...

Yu Tang, Jian-Ying Gu, Yong-Qi Chen et al. · 0 citations
Open access Sep 2026

Single-cell transcriptomic characterization of the immunosuppressive tumor immune microenvironment in hepatocellular carcinoma: implications for SBRT-based radio-immunotherapy

The HCC TIME is profoundly immunosuppressive, driven by myeloid dominance and multi-checkpoint T cell exhaustion, providing direct mechanistic rationale for combining macrophage reprogramming, dual checkpoint blockade, and anti-angiogenic strategies with SBRT.

Xiao-Fei Zhang, Xiao-Han Ma, Sheng Chen et al. · 0 citations
Open access Sep 2026

Tumor γδ T-cell abundance is associated with favorable cancer treatment outcomes

Purpose Clinical response to immune checkpoint blockade (ICB) remains variable. We performed a reference-wide screen to identify immune-cell populations in the tumor microenvironment (TME) associated with benefit across treatment modalities and tumor types. Experimental Design We analyzed pretreatment bulk tumor RNA-se...

Xing-Zhi Niu, Deepali L. Kundnani, Mikaela Dicome et al. · 0 citations
Open access Aug 2026

Single-cell transcriptomics deciphers cancer-associated fibroblast heterogeneity and immune regulatory mechanisms in the bladder cancer tumor microenvironment

Single-cell transcriptomics of publicly available BLCA data identifies two transcriptionally distinct fibroblast states in adjacent tissue and supports an exploratory ligand–receptor interaction framework, warranting prospective validation with primary CAF populations and adequately powered multi-specimen cohorts.

Yan-Dong He, Wen-Long Lu, Guan-Qun Ju et al. · 0 citations
Open access Sep 2026

Effect of Tertiary Lymphoid Structures on Immune Cell Infiltration in the Tumor Microenvironment and Prognosis in Lung Adenocarcinoma

Tertiary lymphoid structures (TLSs) modulate immune responses in various solid tumors, but their comprehensive role in lung adenocarcinoma (LUAD) remains unclear. In this study, we analyzed RNA‐seq data from 539 LUAD patients in The Cancer Genome Atlas (TCGA) and microarray data from 223 samples from the Gene Expressio...

Si-Hong Le, Weidan Fang, Y. Le et al. · 0 citations
Open access Aug 2026

Integrating scRNA-seq and bulk RNA-seq to characterize immune microenvironment and construct a prognostic model for HNSCC

A prognostic model incorporating risk score, clinical stage, and age was established, showing a significant difference in overall survival between high- and low-risk groups, and a generally limited responsiveness of HNSCC to immunotherapy in the absence of specific clinical indicators.

Jia-Yi Chen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.